A population-based cohort study of HRT use and breast cancer in Korea (Q57225591)

https://api.crossref.org/works/10.1177%2F1010539510379392

Breast cancer and hormone-replacement therapy in the Million Women Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010539510379392

Use of hormone replacement therapy by postmenopausal women in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010539510379392

Patterns of use of hormone replacement therapy in one million women in Britain, 1996-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010539510379392

Population-based breast cancer statistics in Korea during 1993-2002: incidence, mortality, and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010539510379392

The changing global patterns of female breast cancer incidence and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010539510379392

Epidemiology and the causes of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010539510379392

2002 annual report of the Korea Central Cancer Registry: based on registered data from 139 hospitals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010539510379392

National cancer incidence for the year 2002 in Korea

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010539510379392

Breast cancer incidence and mortality trends in 16 European countries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010539510379392

Estrogen plus progestin and breast cancer detection by means of mammography and breast biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010539510379392

Reproductive factors and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010539510379392

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010539510379392

Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010539510379392

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010539510379392

Endometrial cancer and hormone-replacement therapy in the Million Women Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010539510379392

Recent declines in hormone therapy utilization and breast cancer incidence: clinical and population-based evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010539510379392

The decrease in breast-cancer incidence in 2003 in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010539510379392

Decline in breast cancer incidence after decrease in utilisation of hormone replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010539510379392

Regional changes in hormone therapy use and breast cancer incidence in California from 2001 to 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010539510379392

Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010539510379392

Breast cancer after use of estrogen plus progestin in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010539510379392

Menstrual and reproductive factors related to the risk of breast cancer in Korea. Ovarian hormone effect on breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010539510379392

Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010539510379392

Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010539510379392

Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010539510379392

Effect of lower doses of conjugated equine estrogens with and without medroxyprogesterone acetate on bone in early postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010539510379392